药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Raltegravir
The metabolism of Raltegravir can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Gavestinel
The metabolism of Gavestinel can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Muraglitazar
The metabolism of Muraglitazar can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Bazedoxifene
The metabolism of Bazedoxifene can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Migalastat
The metabolism of Migalastat can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Ezogabine
The metabolism of Ezogabine can be decreased when combined with Ertugliflozin.
Dioxaphetyl butyrate
Permethrin
Ertugliflozin may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Bepotastine
Ertugliflozin may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Strontium chloride
Ertugliflozin may increase the excretion rate of Strontium chloride which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Testosterone undecanoate
Testosterone undecanoate may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Testosterone enanthate
Testosterone enanthate may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Testosterone cypionate
Testosterone cypionate may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Golodirsen
Ertugliflozin may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Potassium acetate
Ertugliflozin may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Resorcinol
Ertugliflozin may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chloroxylenol
Ertugliflozin may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Pyrithione
Ertugliflozin may increase the excretion rate of Pyrithione which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Solriamfetol
Ertugliflozin may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chromous sulfate
Ertugliflozin may increase the excretion rate of Chromous sulfate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chromium nicotinate
Ertugliflozin may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy.